Natixis Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426M Buy
1,744,076
+191,820
+12% +$44.7M 0.59% 21
2025
Q4
$321M Buy
1,552,256
+47,620
+3% +$9.42M 0.46% 30
2025
Q3
$279M Buy
1,504,636
+197,649
+15% +$33.9M 0.41% 36
2025
Q2
$200M Buy
1,306,987
+3,747
+0.3% +$576K 0.32% 60
2025
Q1
$216M Buy
1,303,240
+281,098
+28% +$44M 0.4% 45
2024
Q4
$148M Sell
1,022,142
-533,871
-34% -$82.7M 0.28% 71
2024
Q3
$252M Buy
1,556,013
+254,861
+20% +$40.6M 0.49% 34
2024
Q2
$190M Sell
1,301,152
-186,044
-13% -$27.7M 0.41% 45
2024
Q1
$235M Buy
1,487,196
+41,806
+3% +$6.65M 0.54% 29
2023
Q4
$227M Sell
1,445,390
-83,536
-5% -$12.8M 0.6% 26
2023
Q3
$238M Sell
1,528,926
-103,538
-6% -$17.1M 0.73% 17
2023
Q2
$270M Buy
1,632,464
+396,111
+32% +$63.9M 0.83% 13
2023
Q1
$192M Sell
1,236,353
-168,967
-12% -$27.3M 0.66% 22
2022
Q4
$248M Buy
1,405,320
+98,436
+8% +$17M 0.94% 9
2022
Q3
$213M Sell
1,306,884
-72,622
-5% -$12.3M 0.9% 11
2022
Q2
$245M Buy
1,379,506
+18,244
+1% +$3.25M 1.08% 7
2022
Q1
$241M Buy
1,361,262
+412,785
+44% +$70.2M 0.92% 10
2021
Q4
$162M Buy
948,477
+77,502
+9% +$12.7M 0.62% 24
2021
Q3
$141M Buy
870,975
+28,078
+3% +$4.79M 0.58% 29
2021
Q2
$139M Buy
842,897
+73,452
+10% +$12.2M 0.65% 20
2021
Q1
$126M Buy
769,445
+19,752
+3% +$3.2M 0.66% 22
2020
Q4
$118M Buy
749,693
+8,112
+1% +$1.2M 0.68% 20
2020
Q3
$110M Buy
741,581
+10,883
+1% +$1.61M 0.69% 20
2020
Q2
$103M Sell
730,698
-139,185
-16% -$20.3M 0.68% 22
2020
Q1
$114M Buy
869,883
+122,794
+16% +$17.4M 0.93% 14
2019
Q4
$109M Buy
747,089
+219,062
+41% +$29.7M 0.77% 18
2019
Q3
$68.3M Sell
528,027
-24,277
-4% -$3.2M 0.54% 37
2019
Q2
$76.9M Buy
552,304
+37,899
+7% +$5.25M 0.63% 26
2019
Q1
$71.9M Buy
514,405
+48,797
+10% +$6.54M 0.63% 28
2018
Q4
$60.1M Sell
465,608
-11,666
-2% -$1.63M 0.59% 35
2018
Q3
$65.9M Buy
477,274
+69,389
+17% +$9.22M 0.58% 29
2018
Q2
$49.5M Sell
407,885
-3,603
-0.9% -$450K 0.47% 40
2018
Q1
$52.7M Buy
411,488
+10,909
+3% +$1.47M 0.52% 33
2017
Q4
$56M Buy
400,579
+19,292
+5% +$2.69M 0.57% 32
2017
Q3
$49.6M Buy
381,287
+4,166
+1% +$552K 0.52% 35
2017
Q2
$49.9M Sell
377,121
-75,299
-17% -$9.61M 0.54% 37
2017
Q1
$56.3M Sell
452,420
-13,535
-3% -$1.62M 0.62% 26
2016
Q4
$53.7M Sell
465,955
-105,499
-18% -$12.2M 0.65% 24
2016
Q3
$67.5M Sell
571,454
-9,495
-2% -$1.15M 0.87% 15
2016
Q2
$70.5M Buy
580,949
+75,870
+15% +$8.62M 0.97% 10
2016
Q1
$54.6M Buy
505,079
+234,418
+87% +$24.3M 0.82% 17
2015
Q4
$27.8M Buy
270,661
+43,417
+19% +$4.37M 0.46% 36
2015
Q3
$21.2M Sell
227,244
-2,474
-1% -$239K 0.37% 50
2015
Q2
$22.4M Sell
229,718
-27,724
-11% -$2.78M 0.38% 39
2015
Q1
$25.9M Buy
257,442
+5,969
+2% +$607K 0.45% 26
2014
Q4
$26.3M Buy
251,473
+6,243
+3% +$658K 0.49% 21
2014
Q3
$26.1M Buy
245,230
+12,942
+6% +$1.34M 0.52% 20
2014
Q2
$24.3M Buy
232,288
+21,414
+10% +$2.16M 0.35% 36
2014
Q1
$20.7M Buy
210,874
+13,903
+7% +$1.29M 0.32% 49
2013
Q4
$18M Buy
196,971
+10,458
+6% +$964K 0.3% 65
2013
Q3
$16.2M Buy
186,513
+27,692
+17% +$2.48M 0.3% 66
2013
Q2
$13.6M Buy
+158,821
New +$13.5M 0.27% 79

Other funds holding JNJ

Natixis Advisors's JNJ Position: Q1 2026 in Review

Natixis Advisors increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $44.7M and bringing the position to 1,744,076 shares worth $426M. The position accounts for 0.59% of the portfolio, ranked #21.

Natixis Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Natixis Advisors held 1,744,076 shares of Johnson & Johnson worth $426M as of Q1 2026.
  • Natixis Advisors bought 191,820 Johnson & Johnson shares in Q1 2026, an estimated $44.7M.
  • Johnson & Johnson made up 0.59% of Natixis Advisors's portfolio in Q1 2026, its #21 holding.
  • Natixis Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.